Pages:
1
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 4981210 or send an email to
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2004-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Youth Violence Prevention Through Community-Level Change Program,
Published: 2004-12-30
Announcement Type: New.
Funding Opportunity Number: CE05020.
Catalog of Federal Domestic Assistance Number: 93.136.
Key Dates:
Letter of Intent Deadline: January 31, 2005.
Application Deadline: March 30, 2005.
I. Funding Opportunity Description
Authority: This program is authorized under both section 391 (a)
and 301 (a) of
NOTICES: Tuberculosis Elimination Advisory Council,
Published: 2004-12-30
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting.
Name: Advisory Council for the Elimination of Tuberculosis (ACET).
Times and Dates: 8:30 a.m.5 p.m., February 16, 2005; 8:30 a.m.
12 p.m., February 17,
Part II: Health and Human Services Department, Centers for Medicare & Medicaid Services,
Published: 2004-12-30
In the October 7, 2004 Federal Register (69 FR 60242), we
published a correction to the final rule that appeared in the August
11, 2004 Federal Register entitled ``Medicare Program; Changes to the
Hospital Inpatient Prospective Payment Systems and Fiscal Year 2005
Rates.'' This amendment corrects errors in that final rule and the
correction of the
RULES: Hospital outpatient prospective payment system and 2005 CY payment rates; Correction,
Published: 2004-12-30
This document corrects technical errors that appear in the
final rule with comment period published in the Federal Register on
November 15, 2004 entitled ``Changes to the Hospital Outpatient
Prospective Payment System and Calendar Year 2005 Payment Rates.'' In
addition, it provides additional information about the calendar year
2005 wage indices
RULES: Medicare+Choice program; managed care provisions; correction,
Published: 2004-12-30
This interim final rule with comment period corrects a
technical error made in the August 22, 2003 final rule ``Modifications
to Medicare Rules'' (68 FR 50840).
NOTICES: National accreditation organizations; approval—; American Association of Blood Banks,
Published: 2004-12-30
This notice announces the re-approval of the American
Association of Blood Banks (AABB) as an accrediting organization for
clinical laboratories under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) program. The initial exemption
[[Page 78427]]
was published in the Federal Register on July 21, 1995. We have
determined that the
NOTICES: Program issuances and coverage decisions; quarterly listing,
Published: 2004-12-30
This notice lists CMS manual instructions, substantive and
interpretive regulations, and other Federal Register notices that were
published from July 2004 through September 2004, relating to the
Medicare and Medicaid programs. This notice provides information on
national coverage determinations (NCDs) affecting specific medical and
health care
NOTICES: Medicare Prescription Drug, Improvement, and Modernization Act of 2003, implementation—; Regulations publication timeline; extension exception and transition period,
Published: 2004-12-30
This notice implements section 902 of the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003, which
establishes a general 3year timeline for publishing a Medicare final
regulation after a proposed regulation or an interim final regulation
has been published. In accordance with the statute, this notice permits
an extension of a
NOTICES: National accreditation organizations; approval—; Medicare Advantage local preferred provider organizations,
Published: 2004-12-30
This final notice announces the approval of the National
Committee for Quality Assurance for deeming authority as a national
accreditation program for local preferred provider organizations that
wish to participate in the Medicare Advantage program.
NOTICES: Skilled nursing facilities prospective payment system and consolidate billing; update; correction,
Published: 2004-12-30
This document corrects technical errors that appeared in the
July 30, 2004 Federal Register, entitled ``Medicare Program;
Prospective Payment System and Consolidated Billing for Skilled Nursing
FacilitiesUpdateNotice.''
NOTICES: Medicare—; Ambulatory Payment Classification Groups Advisory Panel,
Published: 2004-12-30
In accordance with section 10(a) of the Federal Advisory
Committee Act (FACA) (5 U.S.C. Appendix 2), this notice announces the
first biannual meeting of the Ambulatory Payment Classification (APC) Panel for 2005.
The purpose of the Panel is to review the APC groups and their
associated weights and to advise the Secretary of the Department of
NOTICES: Applications for new medical services and technologies add-on payments under hospital inpatient prospective payment system (2006 FY); town hall meeting,
Published: 2004-12-30
This notice, in accordance with section 503 of the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003 (MMA),
announces a Town Hall meeting to discuss fiscal year (FY) 2006
applications for addon payments for new medical services and
technologies under the hospital inpatient prospective payment system
(IPPS). Applicants,
RULES: Chlortetracycline,
Published: 2004-12-30
The Food and Drug Administration (FDA) is amending the animal
drug regulations to add the approved withdrawal time to the limitations
to conditions of use for chlortetracycline Type C medicated feeds for
chickens when fed at the 500 gram per ton level. This change is being
made to improve the accuracy of the regulations.
RULES: Tilmicosin,
Published: 2004-12-30
The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a supplemental new animal drug
application (NADA) filed by Elanco Animal Health which provides for
revised reproductive safety labeling of tilmicosin Type A medicated
article used in medicated swine feeds.
RULES: Secondary direct food additives—; Acidified sodium clorite solutions,
Published: 2004-12-30
The Food and Drug Administration (FDA) is amending the food
additive regulations to provide for the safe use of acidified sodium
chlorite solutions as an antimicrobial agent on finfish and
crustaceans. This action is in response to a petition filed by Alcide
Corp.
NOTICES: Nonclinical and clinical electronic datasets pilot project; request for volunteers,
Published: 2004-12-30
The Food and Drug Administration (FDA), Center for Biologics
Evaluation and Research (CBER), is seeking volunteers to participate in
a pilot project involving the evaluation of various analysis tools to
facilitate the use of electronic datasets for analysis of animal and
human data submitted to FDA by applicants of biologics license
applications
NOTICES: Universal Reagents, Inc.; revocation,
Published: 2004-12-30
The Food and Drug Administration (FDA) is announcing the
revocation of the biologics license (U.S. License No. 0887) issued to
Universal Reagents, Inc., (URI) for the manufacture of Source Plasma. A
notice of opportunity for a hearing on a proposal to revoke the license
was published in the Federal Register of July 10, 2003. URI requested a